Offer - Urjas Oil for just ₹ 1 X
Kenadion 1 Injection 0.5 Ml is a commercial drug that is prescribed in the form of Injection. Primarily, it is used for the treatment of Vitamin K Deficiency. Other than this, Kenadion 1 Injection 0.5 Ml has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Kenadion 1 Injection 0.5 Ml is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Kenadion 1 Injection 0.5 Ml have been listed ahead. Usually, these side effects of Kenadion 1 Injection 0.5 Ml go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Kenadion 1 Injection 0.5 Ml's effect is Moderate during pregnancy and Safe for lactating mothers. It is important to know if Kenadion 1 Injection 0.5 Ml has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Kenadion 1 Injection 0.5 Ml related warnings section.
Some other conditions that can be affected by Kenadion 1 Injection 0.5 Ml are listed in the contraindications section below.
Besides this, Kenadion 1 Injection 0.5 Ml may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Kenadion 1 Injection 0.5 Ml is safe while driving, and is addiction.
Kenadion 1 Injection 0.5 Ml is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Infant (1 month to 2 years) |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Kenadion 1 Injection 0.5 Ml safe for pregnant women?
Kenadion may have some side effects during pregnancy. Pregnant women should discontinue the use of Kenadion, and talk to their doctor, if they notice any discomfort.
Is the use of Kenadion 1 Injection 0.5 Ml safe during breastfeeding?
Kenadion is safe for breastfeeding women.
What is the effect of Kenadion 1 Injection 0.5 Ml on the Kidneys?
Using Kenadion does not have any harmful effects on kidneys.
What is the effect of Kenadion 1 Injection 0.5 Ml on the Liver?
There are no any side effects of Kenadion on the liver.
What is the effect of Kenadion 1 Injection 0.5 Ml on the Heart?
There are no any side effects of Kenadion for the heart.
If you are suffering from any of the following diseases, you should not take Kenadion 1 Injection 0.5 Ml unless your doctor advises you to do so -
Is this Kenadion 1 Injection 0.5 Ml habit forming or addictive?
No, there is no any evidence that Kenadion 1 Injection 0.5 Ml is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Kenadion 1 Injection 0.5 Ml as it does not make you drowsy.
Is it safe?
Yes, Kenadion 1 Injection 0.5 Ml is safe for use.
Is it able to treat mental disorders?
No, the use of Kenadion 1 Injection 0.5 Ml in mental disorders is not effective.
Interaction between Food and Kenadion 1 Injection 0.5 Ml
You can take Kenadion 1 Injection 0.5 Ml with food.
Interaction between Alcohol and Kenadion 1 Injection 0.5 Ml
No research has been done on this till date. Therefore, it is not known what the effect of taking Kenadion 1 Injection 0.5 Ml with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aquamephyton (phytonadione)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 614-616
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1027-1029